Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Halozyme Therapeutics, Inc.
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.
Find out what a historical investment in Halozyme Therapeutics, Inc. would be worth today using our HALO stock calculator.
Market Capitalisation
$8.48B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.8M
High today
$72.19
Low today
$70.25
Open price
$71.68
52-week high
$82.22
52-week low
$51.06
Ready to start your investing journey with Stake?
Open an accountHow do I buy HALO shares in Australia?
Buying HALO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Halozyme Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in HALO
What is the ticker symbol of Halozyme Therapeutics, Inc.?
The ticker symbol for Halozyme Therapeutics, Inc. is HALO.
How much is one share of HALO?
One share of HALO is valued at $70.42 as of 10 June 2026.
What is the market capitalisation of Halozyme Therapeutics, Inc. HALO?
As of 10 June 2026 Halozyme Therapeutics, Inc. has a market cap of $8.48B.
What is the P/E ratio of HALO?
The Price to Earnings ratio of HALO is 25.71.
What is the Earnings Per Share of HALO?
The Earnings Per Share of HALO is $2.78.
What is the 52-week high for Halozyme Therapeutics, Inc. stock?
The Halozyme Therapeutics, Inc. 52-week high stock price is $82.22.
What is the 52-week low for Halozyme Therapeutics, Inc. stock?
The Halozyme Therapeutics, Inc. 52-week low stock price is $51.06.
Can I buy HALO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HALO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in HALO on Stake
- Buy HALO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of HALO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
HALO related stocks